ArticleOphthalmology. Retina

Serious Adverse Events with Bevacizumab or Ranibizumab for Age-related Macular Degeneration: Meta-analysis of Individual Patient Data.

Bevacizumab-Ranibizumab International Trials GroupPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.